Clovis Oncology Denmark ApS: Financial statements 2021
CVR: 38721682
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Clovis Oncology Denmark ApS (CVR 38721682) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,539,039 and a net result of DKK 46,336 compared with DKK 43,896 the year before. That is a decrease of 7.2% compared with the year before. Equity in the 2021 report amounted to DKK 299,062. The solvency ratio was 26.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,539,039
- Profit/Loss
- DKK 46,336
- Equity
- DKK 299,062
- Total Assets
- DKK 1,125,175
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1.5M | 46K | 299K | 1 |
| 2020 | - | 1.7M | 44K | 253K | 1 |
| 2019 | - | 1.9M | 65K | 209K | 1 |
| 2018 | - | 4.5M | 21K | 50K | 2 |
Official annual report
Find more companies like Clovis Oncology Denmark ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Clovis Oncology Denmark ApS has published its annual report for 2020. Gross profit came to DKK 1,657,621, and the net result was DKK 43,896.
About Clovis Oncology Denmark ApS
Clovis Oncology Denmark ApS was a Danish company of the type Anpartsselskab based in Allerød, founded in 2017. The company has been dissolved on 5 June 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -1,276,497 and a net result of DKK -1,290,249 compared with DKK -683,391 the year before. Equity in the 2023 report amounted to DKK -356,205.